Historically, we have had qualified experts and teams for different technology disciplines living in Hong Kong, but we lacked the long-term investment capital to drive innovation…
In Conversation
Manufacturing, R&D, and clinical trials are all important, but pricing is just as crucial. Making the domestic market more difficult to access puts Belgium in a…
As an industry, we have a responsibility to collect information on reported outcomes and work with health authorities to ensure our products are doing what we…
Building biotechnology unicorns only in Hong Kong is challenging because of the small size of the local market, but it is possible, and we have shown…
Our state-of-the-art R&D capabilities and history of successful translation of good science into numerous spin-offs and winners have put us at the forefront of the global…
The first step of any start-up is the most challenging, as students and young graduates do not have the financial means to go forward, so setting…
My goal is to introduce the proven Japanese standard in dialysis treatment to Europe. By adopting their practices, we can make a profound impact, drastically extending…
The Blueprint identifies a need for the development of Hong Kong’s upstream basic research, midstream technology transfer, and downstream industrial development. This represents a shift from…
It is time to act and realise the critical importance of the healthcare sector both from a medical and an economic perspective
I believe AI in general and in healthcare, in particular, will lead to a ... revolution in knowledge and accelerate engagement by allowing us to step…
BMS has been able to deliver for Belgian patients and physicians, in partnership with the health minister and his team
The Middle East has amazing potential, but you must always think outside the box here
